Also... this seems strongly at odds with the last appendix 4C. The company stated:
Strong balance sheet to advance ResApp through commercialisation. The company held
cash of $3.9 million as of December 31, 2019. ResApp received a $1.8 million R&D tax
incentive cash rebate from its FY2019 R&D spend during the quarter. A significant proportion
of R&D spend for the current financial year will also be eligible for the R&D tax incentive.
The company claimed to have sufficient funds to "advance ResApp through commercialisation". Yet now we suddenly need cash. I'm feeling just a little bit misled right now. And that has legal implications for the directors.
Also... this seems strongly at odds with the last appendix 4C....
-
- There are more pages in this discussion • 344 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| RAP (ASX) Chart |
Day chart unavailable